Female-to-male HIV transmission risk doubles during pregnancy: StudyMay 24th, 2010 - 12:11 pm ICT by ANI
Washington, May 24 (ANI): Previous studies have shown that women of reproductive age, especially when pregnant are highly prone to HIV infection. Now, a new study has warned that pregnancy is a time when men also are at higher risk. In fact, their risk doubles if their partner is both HIV-infected and pregnant.
Many women remain sexually active during pregnancy and may or may not wish to negotiate condom use with their male partners - especially if they wish to get pregnant.
Biological changes that occur during pregnancy may make women more infectious than they would be otherwise, explains Nelly Mugo, of the University of Nairobi & Kenyatta National Hospital in Nairobi and the University of Washington in Seattle.
A study was conducted up to two years for 1,085 couples in which the male was infected and 2,236 couples in which the female was infected to understand the different circumstances and determinants that may contribute to HIV risk.
In their analysis, they found that pregnancy was associated with increased risk of both female-to-male and male-to-female HIV transmission.
But for women with an HIV- infected partner, the study found that factors other than pregnancy also likely contributed to this increased risk, such as sexual behavior. In men, however, the link between pregnancy and HIV risk was much clearer, even after considering whether or not they had engaged in unprotected sex or were circumcised.
Microbicides — substances designed to be applied topically on the inside of the rectum or vagina - are under active investigation as a method for women to use to protect against HIV.
The study, which involved applying a single dose of tenofovir gel hours before women gave birth by caesarean delivery, was conducted as a first step toward determining if use of a vaginal microbicide during pregnancy is safe for women and their babies.
The active ingredient in tenofovir gel is an antiretroviral that is approved as an oral drug and used as part of the standard HIV treatment regimen.
In the current trial, which involved healthy, uninfected pregnant women, the amount of drug found in umbilical cord blood was 40-times lower than cord blood levels noted in these other studies after oral dosing, and the amount that got absorbed into the maternal blood was at levels 50- to 100-times lower.
In addition to finding very low levels of drug, the researchers also reported there were no serious side effects attributed to the gel in either the mothers or their newborns. Based on these results, researchers now plan to conduct a larger study of tenofovir gel in both pregnant and breastfeeding women.
Because no information has been available to know whether using a candidate microbicide during pregnancy is safe, women who participate in clinical trials must use contraception, and if women become pregnant, they must stop using study product- at a time when protection may be needed the most.
The results were presented today at the International Microbicides Conference (M2010) in Pittsburgh. (ANI)
- Vaginal gel 'can cut HIV risk by 39pct in women' - Jul 20, 2010
- A Vaginal Gel Represents A Breakthrough In The War Against AIDS - Jul 20, 2010
- Anti-HIV vaginal gel deemed safe for rectal use too - Mar 01, 2011
- Vaginal gel halves women's chance of getting AIDS - Jul 20, 2010
- 'Pregnant women more vulnerable to Hepatitis E-induced liver failure' (July 28 is World Hepatitis Day) - Jul 26, 2012
- Anti-HIV gel shows promise in Aids prevention - Feb 10, 2009
- Not just a handmaiden: Critical role of social science in HIV Prevention Research - May 25, 2010
- A new gel may prevent the HIV/AIDS infection in women - Jul 20, 2010
- State of the ART of microbicides to prevent HIV - May 24, 2010
- Lubricant use with anal sex may raise HIV risk - May 26, 2010
- Microbicide trial results signal end of one chapter, focus turns to promising ARV-based candidates - Dec 14, 2009
- Pregnancy stress can affect baby's iron status: Study - Apr 30, 2012
- Why TB Matters to Women's Health? - Aug 17, 2010
- First ever pill to beat HIV under FDA consideration - May 10, 2012
- Heterosexual HIV 'in China aggravated by unprotected sex, drugs' - Nov 09, 2010
Tags: active ingredient, antiretroviral, biological changes, caesarean delivery, condom use, determinants, hiv infection, hiv risk, hiv transmission, kenyatta national hospital, male partners, microbicide, mugo, pregnancy study, rectum, risk doubles, sexual behavior, tenofovir, university of nairobi, unprotected sex